ALFRED D KINGSLEY
CIK 1229339 · Chairman · last filed 2023-07-03
ALFRED D KINGSLEY is a Chairman who has filed 59 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for LCTX, was dated Jul 3, 2023. Across all open-market trades the lifetime net is −$3.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.42M
5
59
-$3.23M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LCTX | Chairman | 5,845,596 | $1.27 | $7.42M | $0 | 5 | 2023-07-03 |
| Insight Molecular Diagnostics Inc. (OCX) Delisted | Director | 507,878 | $3.20 | $1.63M | $7.9K | 15 | 2023-06-27 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | See Remarks | 5,846,906 | — | — | -$3.27M | 33 | 2018-07-03 |
| Asterias Biotherapeutics, Inc. (AST.WS) Delisted | Director | 9,000 | — | — | $11.7K | 1 | 2016-06-10 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | Director | 5,000 | — | — | $21.6K | 3 | 2016-03-01 |
Recent Filings
59 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-07-03 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2023-06-27 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2023-06-15 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +30,000 | $6.4K | EDGAR |
| 2022-12-27 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +25,000 | $7.1K | EDGAR |
| 2022-08-17 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Mixed | +20,000 | $9.7K | EDGAR |
| 2022-07-19 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Exer (M) | +10,000 | $0 | EDGAR |
| 2022-07-06 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2021-07-01 | LCTX | Grant (A) | — | $0 | EDGAR |
| 2021-06-28 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-23 | LCTX | Exer (M) | +61,800 | $136.0K | EDGAR |